Phase II/III CRO Services

Dedicated Resources For Helping You Reach Your Goals Faster

Cmed has the solutions, people, and processes in place to successfully push your Phase II or Phase III clinical trial across the line.  Through our 20+ years of experience and 15+ of design and delivery of virtual and patient centric trials, we’ve developed processes to support even the most complicated patient identification, product manufacture, and dose administration timeframes.

Your studies are safeguarded and enhanced through Cmed’s…

  • Technology providing safety and medical oversight using real-time visualizations to provide insights into your study data.
  • Dedicated Phase II and III study teams experts who can support agency engagement, program strategy, protocol development and feasibility.
  • Established global relationships with 3rd party data handling and specialist laboratories, imaging, eCOA, and other key service providers.
  • Powerful Integrations with Home Visit technology for online medical review and tracking, cross-functional interactive visualizations, eConsent, and other systems such as eSAE, eCTD, eTMF, and eSource.
  • Successful record of delivery in fuctional and composite service models.

Employ innovative strategies and avoid hurdles in your next Phase II and III studies by partnering with Cmed. 

Why work with us?

By the numbers:


Site CDAs as fast as 2 days


Database locks within 4 weeks of LPLV


Project plans final in 14 days


Central IRB submission and approval as fast as 29 days


100% of sites activated and databases live before FPI


TFLs delivered within 10 days of database lock


4,400 sites across US, EU, and APAC


Studies in 78 countries

Supporting Resources


Get in touch

Let’s support you on your next project

    Related solutions

    Other ways we support you